The Discounted Cash Flow (DCF) valuation of BioInvent International AB (BINV.ST) is (38,823,404.26) SEK. With the latest stock price at 21.60 SEK, the upside of BioInvent International AB based on DCF is -179738082.7%.
Based on the latest price of 21.60 SEK and our DCF valuation, BioInvent International AB (BINV.ST) is a sell. selling BINV.ST stocks now will result in a potential gain of 179738082.7%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.3% - 8.1% | 6.7% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (302,391,954.38) - (20,785,554.39) | (38,823,404.26) |
| Upside | -1399962851.8% - -96229518.4% | -179738082.7% |